posted by ALLpaQ Packaging
July, 11th, 2022
Pharmaceutical Industry News Single-use News
Press Release: Medi-Tech Insights
The Global Single-use Assemblies Market, which was valued at $2.25 billion in 2021, is set to grow 22% over the next 5 years to reach $6.1 Billion by 2026.
Key factors accelerating the Single-use Assemblies Market include the advantage of ready-to-use assemblies, funding for single-use manufacturing, a buoyant biologics and vaccines market, and increasing biopharmaceutical research and development.
What is a single-use assembly?
A single-use assembly is a ready-to-use custom-made solution which comprises a range of plastic components assembled into one whole, based on a customer-specific design.
Bioprocessing end users usually undertake the in-house assembling of single-use systems. If connections between the different components are not made correctly, it might result in cross-contamination and leakage which in turn might lead to production delays. Ready-to-use single-use assemblies aptly address these issues.
Some of the key benefits, include:
- Faster implementation of single-use assembly components in the bioprocess cycle.
- Fewer risks of cross-contamination and leakage.
- Reduced labour, expense, and time for end-users resulting in cost reduction.
The elimination of cleaning and downtime are also among the advantages that are bolstering single-use assemblies market demand
Favourable funding for single-use manufacturing
Favourable funding for single-use solutions manufacturing is also identified as a trigger factor in the growth of single-use assemblies market. Over the past 10 years, single-use assemblies and technologies have seen a significant adoption across the world.
Integrating single-use equipment into bioprocessing:
- Decreases facility set-up expenses
- Lowers cleaning costs & cross-product/batch contamination risks
- Increases product integrity, reduces downtime
- Improves facility flexibility and adaptability
A single-use assembly provides everything a bio processor requires: bags, tubing, connectors, and filters. It provides flexible, customized single-use solutions to accelerate pharmaceutical drug development and manufacturing. Ready-to-use assemblies allow the development and production of products in a wide range of sizes and for a variety of diseases.
It is a critical component in the supply chain for the production of vaccines and medications around the world.
More on the global single-use assemblies market
The global single-use assemblies market is marked by the presence of major industry players such as Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech, Danaher Corporation, Merck KGaA, Avantor, Inc., Saint-Gobain, and others.
Visit Medi-Tech to discover more detailed research insights into the single-use assemblies market.
TAGS:
Biopharmaceutical, Single-use, single-use assemblies,
SHARE:
Author
ALLpaQ
Packaging
ALLpaQ is the market leader in the design of innovative pharma containers and fluid management solutions.